Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Exhaled Volatile Organic Compounds Are Able to Discriminate between Neutrophilic and Eosinophilic Asthma.

Schleich FN, Zanella D, Stefanuto PH, Bessonov K, Smolinska A, Dallinga JW, Henket M, Paulus V, Guissard F, Graff S, Moermans C, Wouters EFM, Van Steen K, van Schooten FJ, Focant JF, Louis R.

Am J Respir Crit Care Med. 2019 Aug 15;200(4):444-453. doi: 10.1164/rccm.201811-2210OC.

PMID:
30973757
2.

Comparing patterns of volatile organic compounds exhaled in breath after consumption of two infant formulae with a different lipid structure: a randomized trial.

Smolinska A, Baranska A, Dallinga JW, Mensink RP, Baumgartner S, van de Heijning BJM, van Schooten FJ.

Sci Rep. 2019 Jan 24;9(1):554. doi: 10.1038/s41598-018-37210-5.

3.

Limited clinical value of exhaled volatile organic compound measurements in childhood asthma.

Fuglsbjerg MG, Rasmussen MA, Hansen KS, Smolinska A, Dallinga JW, van Schooten FJ, Stokholm J, Bønnelykke K, Bisgaard H, Chawes BL.

ERJ Open Res. 2018 Nov 12;4(4). pii: 00026-2018. doi: 10.1183/23120541.00026-2018. eCollection 2018 Oct.

4.

Exposure to genotoxic compounds alters in vitro cellular VOC excretion.

Fijten RRR, Smolinska A, Shi Q, Pachen DM, Dallinga JW, Boots AW, van Schooten FJ.

J Breath Res. 2018 Jan 3;12(2):027101. doi: 10.1088/1752-7163/aa9080.

PMID:
28972195
5.

The necessity of external validation in exhaled breath research: a case study of sarcoidosis.

Fijten RRR, Smolinska A, Drent M, Dallinga JW, Mostard R, Pachen DM, van Schooten FJ, Boots AW.

J Breath Res. 2017 Nov 29;12(1):016004. doi: 10.1088/1752-7163/aa8409.

PMID:
28775245
6.

The potential of volatile organic compounds for the detection of active disease in patients with ulcerative colitis.

Smolinska A, Bodelier AG, Dallinga JW, Masclee AA, Jonkers DM, van Schooten FJ, Pierik MJ.

Aliment Pharmacol Ther. 2017 May;45(9):1244-1254. doi: 10.1111/apt.14004. Epub 2017 Feb 26.

7.

Factors that influence the volatile organic compound content in human breath.

Blanchet L, Smolinska A, Baranska A, Tigchelaar E, Swertz M, Zhernakova A, Dallinga JW, Wijmenga C, van Schooten FJ.

J Breath Res. 2017 Feb 22;11(1):016013. doi: 10.1088/1752-7163/aa5cc5.

PMID:
28140379
8.

Volatile organic compounds in breath as markers for irritable bowel syndrome: a metabolomic approach.

Baranska A, Mujagic Z, Smolinska A, Dallinga JW, Jonkers DM, Tigchelaar EF, Dekens J, Zhernakova A, Ludwig T, Masclee AA, Wijmenga C, van Schooten FJ.

Aliment Pharmacol Ther. 2016 Jul;44(1):45-56. doi: 10.1111/apt.13654. Epub 2016 May 2.

9.

Association between exhaled inflammatory markers and asthma control in children.

Van Vliet D, Smolinska A, Jöbsis Q, Rosias PP, Muris JW, Dallinga JW, van Schooten FJ, Dompeling E.

J Breath Res. 2016 Feb 19;10(1):016014. doi: 10.1088/1752-7155/10/1/016014.

PMID:
26893372
10.

Volatile organic compounds discriminate between eosinophilic and neutrophilic inflammation in vitro.

Schleich FN, Dallinga JW, Henket M, Wouters EF, Louis R, Van Schooten FJ.

J Breath Res. 2016 Feb 1;10(1):016006. doi: 10.1088/1752-7155/10/1/016006.

11.

A profile of volatile organic compounds in exhaled air as a potential non-invasive biomarker for liver cirrhosis.

Pijls KE, Smolinska A, Jonkers DM, Dallinga JW, Masclee AA, Koek GH, van Schooten FJ.

Sci Rep. 2016 Jan 29;6:19903. doi: 10.1038/srep19903.

12.

Dynamic collection and analysis of volatile organic compounds from the headspace of cell cultures.

Baranska A, Smolinska A, Boots AW, Dallinga JW, van Schooten FJ.

J Breath Res. 2015 Oct 15;9(4):047102. doi: 10.1088/1752-7155/9/4/047102.

PMID:
26469548
13.

Volatile Organic Compounds in Exhaled Air as Novel Marker for Disease Activity in Crohn's Disease: A Metabolomic Approach.

Bodelier AG, Smolinska A, Baranska A, Dallinga JW, Mujagic Z, Vanhees K, van den Heuvel T, Masclee AA, Jonkers D, Pierik MJ, van Schooten FJ.

Inflamm Bowel Dis. 2015 Aug;21(8):1776-85. doi: 10.1097/MIB.0000000000000436.

PMID:
26199990
14.

Exhaled biomarkers and gene expression at preschool age improve asthma prediction at 6 years of age.

Klaassen EM, van de Kant KD, Jöbsis Q, van Schayck OC, Smolinska A, Dallinga JW, van Schooten FJ, den Hartog GJ, de Jongste JC, Rijkers GT, Dompeling E.

Am J Respir Crit Care Med. 2015 Jan 15;191(2):201-7. doi: 10.1164/rccm.201408-1537OC.

PMID:
25474185
15.

Defining adult asthma endotypes by clinical features and patterns of volatile organic compounds in exhaled air.

Meyer N, Dallinga JW, Nuss SJ, Moonen EJ, van Berkel JJ, Akdis C, van Schooten FJ, Menz G.

Respir Res. 2014 Nov 28;15:136. doi: 10.1186/s12931-014-0136-8.

16.

Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.

Dallinga JW, Smolinska A, van Schooten FJ.

Methods Mol Biol. 2014;1198:251-63. doi: 10.1007/978-1-4939-1258-2_16.

PMID:
25270934
17.

Profiling of volatile organic compounds in exhaled breath as a strategy to find early predictive signatures of asthma in children.

Smolinska A, Klaassen EM, Dallinga JW, van de Kant KD, Jobsis Q, Moonen EJ, van Schayck OC, Dompeling E, van Schooten FJ.

PLoS One. 2014 Apr 21;9(4):e95668. doi: 10.1371/journal.pone.0095668. eCollection 2014. Erratum in: PLoS One. 2014;9(8):e105447.

18.

Identification of microorganisms based on headspace analysis of volatile organic compounds by gas chromatography-mass spectrometry.

Boots AW, Smolinska A, van Berkel JJ, Fijten RR, Stobberingh EE, Boumans ML, Moonen EJ, Wouters EF, Dallinga JW, Van Schooten FJ.

J Breath Res. 2014 Jun;8(2):027106. doi: 10.1088/1752-7155/8/2/027106. Epub 2014 Apr 16.

PMID:
24737039
19.

Current breathomics--a review on data pre-processing techniques and machine learning in metabolomics breath analysis.

Smolinska A, Hauschild AC, Fijten RR, Dallinga JW, Baumbach J, van Schooten FJ.

J Breath Res. 2014 Jun;8(2):027105. doi: 10.1088/1752-7155/8/2/027105. Epub 2014 Apr 8. Review.

PMID:
24713999
20.

Profile of volatile organic compounds in exhaled breath changes as a result of gluten-free diet.

Baranska A, Tigchelaar E, Smolinska A, Dallinga JW, Moonen EJ, Dekens JA, Wijmenga C, Zhernakova A, van Schooten FJ.

J Breath Res. 2013 Sep;7(3):037104. doi: 10.1088/1752-7155/7/3/037104. Epub 2013 Jun 18.

PMID:
23774130
21.

Exhaled volatile organic compounds predict exacerbations of childhood asthma in a 1-year prospective study.

Robroeks CM, van Berkel JJ, Jöbsis Q, van Schooten FJ, Dallinga JW, Wouters EF, Dompeling E.

Eur Respir J. 2013 Jul;42(1):98-106. doi: 10.1183/09031936.00010712. Epub 2013 May 3.

22.

Exhaled breath profiling in diagnosing wheezy preschool children.

van de Kant KD, van Berkel JJ, Jöbsis Q, Lima Passos V, Klaassen EM, van der Sande L, van Schayck OC, de Jongste JC, van Schooten FJ, Derks E, Dompeling E, Dallinga JW.

Eur Respir J. 2013 Jan;41(1):183-8. doi: 10.1183/09031936.00122411.

23.

Non-alcoholic steatohepatitis: a non-invasive diagnosis by analysis of exhaled breath.

Verdam FJ, Dallinga JW, Driessen A, de Jonge C, Moonen EJ, van Berkel JB, Luijk J, Bouvy ND, Buurman WA, Rensen SS, Greve JW, van Schooten FJ.

J Hepatol. 2013 Mar;58(3):543-8. doi: 10.1016/j.jhep.2012.10.030. Epub 2012 Nov 7.

PMID:
23142062
24.

The versatile use of exhaled volatile organic compounds in human health and disease.

Boots AW, van Berkel JJ, Dallinga JW, Smolinska A, Wouters EF, van Schooten FJ.

J Breath Res. 2012 Jun;6(2):027108. doi: 10.1088/1752-7155/6/2/027108. Epub 2012 May 23. Review.

PMID:
22621865
25.

Breath analysis as a potential diagnostic tool for tuberculosis.

Kolk AH, van Berkel JJ, Claassens MM, Walters E, Kuijper S, Dallinga JW, van Schooten FJ.

Int J Tuberc Lung Dis. 2012 Jun;16(6):777-82. doi: 10.5588/ijtld.11.0576. Epub 2012 Apr 9.

PMID:
22507235
26.

Metabolomics of volatile organic compounds in cystic fibrosis patients and controls.

Robroeks CM, van Berkel JJ, Dallinga JW, Jöbsis Q, Zimmermann LJ, Hendriks HJ, Wouters MF, van der Grinten CP, van de Kant KD, van Schooten FJ, Dompeling E.

Pediatr Res. 2010 Jul;68(1):75-80. doi: 10.1203/00006450-201011001-00143.

PMID:
20351658
27.

A profile of volatile organic compounds in breath discriminates COPD patients from controls.

Van Berkel JJ, Dallinga JW, Möller GM, Godschalk RW, Moonen EJ, Wouters EF, Van Schooten FJ.

Respir Med. 2010 Apr;104(4):557-63. doi: 10.1016/j.rmed.2009.10.018. Epub 2009 Nov 10.

28.

Volatile organic compounds in exhaled breath as a diagnostic tool for asthma in children.

Dallinga JW, Robroeks CM, van Berkel JJ, Moonen EJ, Godschalk RW, Jöbsis Q, Dompeling E, Wouters EF, van Schooten FJ.

Clin Exp Allergy. 2010 Jan;40(1):68-76. doi: 10.1111/j.1365-2222.2009.03343.x. Epub 2009 Sep 28.

PMID:
19793086
29.

Potential role of cytochrome P450-1B1 in the metabolic activation of 4-aminobiphenyl in humans.

Ketelslegers HB, Godschalk RW, Eskens BJ, Dallinga JW, Gottschalk RW, van Schooten FJ, van Delft JH, Kleinjans JC.

Mol Carcinog. 2009 Aug;48(8):685-91. doi: 10.1002/mc.20530.

PMID:
19274671
30.

Development of accurate classification method based on the analysis of volatile organic compounds from human exhaled air.

Van Berkel JJ, Dallinga JW, Möller GM, Godschalk RW, Moonen E, Wouters EF, Van Schooten FJ.

J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Jan 1;861(1):101-7. Epub 2007 Nov 19.

PMID:
18055279
31.

Neutrophil-mediated formation of carcinogenic N-nitroso compounds in an in vitro model for intestinal inflammation.

Vermeer IT, Henderson LY, Moonen EJ, Engels LG, Dallinga JW, van Maanen JM, Kleinjans JC.

Toxicol Lett. 2004 Dec 30;154(3):175-82.

PMID:
15501609
32.

CYP1A2 and NAT2 genotype/phenotype relations and urinary excretion of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in a human dietary intervention study.

Moonen HJ, Moonen EJ, Maas L, Dallinga JW, Kleinjans JC, de Kok TM.

Food Chem Toxicol. 2004 Jun;42(6):869-78.

PMID:
15110095
33.
34.

Decreased human semen quality and organochlorine compounds in blood.

Dallinga JW, Moonen EJ, Dumoulin JC, Evers JL, Geraedts JP, Kleinjans JC.

Hum Reprod. 2002 Aug;17(8):1973-9.

PMID:
12151423
35.

Helicobacter pylori does not mediate the formation of carcinogenic N-nitrosamines.

Vermeer IT, Gerrits MM, Moonen EJ, Engels LG, Dallinga JW, Kleinjans JC, van Maanen JM, Kuipers EJ, Kusters JG.

Helicobacter. 2002 Jun;7(3):163-9.

PMID:
12047321
36.

Effects of oral administration of N-acetyl-L-cysteine: a multi-biomarker study in smokers.

Van Schooten FJ, Besaratinia A, De Flora S, D'Agostini F, Izzotti A, Camoirano A, Balm AJ, Dallinga JW, Bast A, Haenen GR, Van't Veer L, Baas P, Sakai H, Van Zandwijk N.

Cancer Epidemiol Biomarkers Prev. 2002 Feb;11(2):167-75. Erratum in: Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1846. Besarati Nia, Ahmad [corrected to Besaratinia, Ahmad].

37.

Intragastric volatile N-nitrosamines, nitrite, pH, and Helicobacter pylori during long-term treatment with omeprazole.

Vermeer IT, Engels LG, Pachen DM, Dallinga JW, Kleinjans JC, van Maanen JM.

Gastroenterology. 2001 Sep;121(3):517-25.

PMID:
11522734
38.

Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1,GSTT1, NAT1 and NAT2.

Godschalk RW, Dallinga JW, Wikman H, Risch A, Kleinjans JC, Bartsch H, Van Schooten FJ.

Pharmacogenetics. 2001 Jul;11(5):389-98.

PMID:
11470992
39.

Determination of N-nitrosodimethylamine in artificial gastric juice by gas chromatography-mass spectrometry and by gas chromatography-thermal energy analysis.

Dallinga JW, Krul CA, Tenfelde A, Moonen EJ, Vermeer IT, van Doorn D, Schothorst RC.

Eur J Cancer Prev. 2001 Jun;10(3):265-8.

PMID:
11432714
40.

Excretion of volatile nitrosamines in a rural population in relation to food and drinking water consumption.

Levallois P, Ayotte P, Van Maanen JM, Desrosiers T, Gingras S, Dallinga JW, Vermeer IT, Zee J, Poirier G.

Food Chem Toxicol. 2000 Nov;38(11):1013-9.

PMID:
11038239
41.

Effect of ascorbic acid and green tea on endogenous formation of N-nitrosodimethylamine and N-nitrosopiperidine in humans.

Vermeer IT, Moonen EJ, Dallinga JW, Kleinjans JC, van Maanen JM.

Mutat Res. 1999 Jul 16;428(1-2):353-61.

PMID:
10518007
42.

Volatile N-nitrosamine formation after intake of nitrate at the ADI level in combination with an amine-rich diet.

Vermeer IT, Pachen DM, Dallinga JW, Kleinjans JC, van Maanen JM.

Environ Health Perspect. 1998 Aug;106(8):459-63.

43.

The use of 4-aminobiphenyl hemoglobin adducts and aromatic DNA adducts in lymphocytes of smokers as biomarkers of exposure.

Dallinga JW, Pachen DM, Wijnhoven SW, Breedijk A, van 't Veer L, Wigbout G, van Zandwijk N, Maas LM, van Agen E, Kleinjans JC, van Schooten FJ.

Cancer Epidemiol Biomarkers Prev. 1998 Jul;7(7):571-7.

44.

Formation of nitrosamines during consumption of nitrate- and amine-rich foods, and the influence of the use of mouthwashes.

van Maanen JM, Pachen DM, Dallinga JW, Kleinjans JC.

Cancer Detect Prev. 1998;22(3):204-12.

PMID:
9618041
45.

Volatile N-nitrosamines in gastric juice of patients with various conditions of the gastrointestinal tract determined by gas chromatography-mass spectrometry and related to intragastric pH and nitrate and nitrite levels.

Dallinga JW, Pachen DM, Lousberg AH, van Geel JA, Houben GM, Stockbrügger RW, van Maanen JM, Kleinjans JC.

Cancer Lett. 1998 Feb 27;124(2):119-25.

PMID:
9500200
46.

Polycyclic aromatic hydrocarbons in whiskies.

Kleinjans JC, Moonen EJ, Dallinga JW, Albering HJ, van den Bogaard AE, van Schooten FJ.

Lancet. 1996 Dec 21-28;348(9043):1731. No abstract available.

PMID:
8973440
47.

Determination of volatile N-nitrosamines in gastric juice and in urine by gas chromatography-mass spectrometry.

Dallinga JW, Pachen DM, Kleinjans JC.

Eur J Cancer Prev. 1996 Sep;5 Suppl 1:63-6. No abstract available.

PMID:
8972295
48.

Environmental exposure to N-nitroso compounds and their precursors.

van Maanen JM, Dallinga JW, Kleinjans JC.

Eur J Cancer Prev. 1996 Sep;5 Suppl 1:29-31. Review. No abstract available.

PMID:
8972289
49.

Nitrate contamination of drinking water: relationship with HPRT variant frequency in lymphocyte DNA and urinary excretion of N-nitrosamines.

van Maanen JM, Welle IJ, Hageman G, Dallinga JW, Mertens PL, Kleinjans JC.

Environ Health Perspect. 1996 May;104(5):522-8.

Supplemental Content

Loading ...
Support Center